BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAB8. A total of 38 filers reported holding BRIDGEBIO PHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44 | -97.8% | 46,000 | -98.2% | 0.00% | -100.0% |
| Q2 2023 | $1,969 | -89.2% | 2,500,000 | -89.9% | 0.00% | -91.7% |
| Q1 2023 | $18,264 | +55.2% | 24,649,000 | -5.7% | 0.02% | +50.0% |
| Q4 2022 | $11,767 | -99.9% | 26,149,000 | 0.0% | 0.02% | -30.4% |
| Q3 2022 | $15,658,000 | -21.8% | 26,149,000 | -27.7% | 0.02% | -14.8% |
| Q2 2022 | $20,019,000 | -31.4% | 36,149,000 | -27.6% | 0.03% | -20.6% |
| Q1 2022 | $29,170,000 | -35.7% | 49,949,000 | -18.8% | 0.03% | -29.2% |
| Q4 2021 | $45,338,000 | -21.0% | 61,500,000 | +48.2% | 0.05% | -26.2% |
| Q3 2021 | $57,362,000 | +39.5% | 41,500,000 | +66.0% | 0.06% | +41.3% |
| Q2 2021 | $41,125,000 | +231.4% | 25,000,000 | +233.3% | 0.05% | +206.7% |
| Q1 2021 | $12,408,000 | – | 7,500,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARISTEIA CAPITAL, L.L.C. | 100,224,000 | $60,134,000 | 1.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 80,000,000 | $47,402,000 | 1.06% |
| Affinity Asset Advisors, LLC | 7,500,000 | $4,380,000 | 0.70% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 49,229,000 | $28,932,000 | 0.67% |
| Context Capital Management, LLC | 16,489 | $9,850,000 | 0.64% |
| CONTRARIAN CAPITAL MANAGEMENT, L.L.C. | 6,000,000 | $3,444,000 | 0.46% |
| TFG Asset Management GP Ltd | 15,000,000 | $8,942,000 | 0.41% |
| WOLVERINE ASSET MANAGEMENT LLC | 58,069,000 | $33,968,000 | 0.33% |
| SILVERBACK ASSET MANAGEMENT LLC | 4,000,000 | $2,333,000 | 0.32% |
| Ionic Capital Management LLC | 4,500,000 | $2,676,000 | 0.30% |